The uplisting is one area in which I feel pretty good about

New Post Public Reply Private Reply Replies (3) Message Board
Respert24 CDiddy #48212
1,067
The uplisting is one area in which I feel pretty good about the timeline. The vast majority of it seems to be meeting the listing requirements and the NASDAQ folks doing their due diligence. If we meet the requirements, which all the key folks have said we do, then I anticipate it falling in line.

I think the lingering doubt about timelines that many of us feel is completely valid but also a result of the constantly changing landscape. I remember one of the conference calls we had after the EIND's were in full swing and Dr. J said that they went to the FDA on something like 4 previous occasions asking for emergency use. The first time was after the first few patients at Montefiore and then as great results kept occurring they kept asking.

Hell, you can't blame them for asking as well as for thinking it had a chance of working. That's why we're all here, after all. Because we see it already. The FDA either doesn't see it (yet) or they see it but aren't about to get burned by a small company when all eyes across the world are on them to fix this problem. (or of course there is big pharma influence keeping it down) But the point is our leaders have been gameplanning for a timeline to approval that has shifted constantly as new data and new hope arrives on a near constant basis. If X happens you do Y and Z. If X gets delayed you scrap Y and maybe Z, and then move over to U and V. A week later there's new results and you're back on the Y and Z train.

All of the ancillary but important factors have to change with the end goal. The deal you're going to get from an institutional investor or the amount of product you are going to contractually sign on to receive is going to swing wildly as things like results, approval, and licensing/partnerships advance. They are all tied together.

I really felt like NP's goal has been (pre-covid) to get as many balls in the air that he can. Balls that are just far enough along to prove what Leronlimab can do, but not so far that it requires a ton of money and time to get there. The idea being that we would become more valuable both for shareholders and for a potential buyout. And as new opportunities like Covid presented themselves it went from "let's see if we can test the waters a little" to "hey guys, we may have something special here" and when you have limited resources you have to dead-end a few paths to cut your new one.

This theory can help explain why things popped up and then seemed to disappear a lot over the last couple months. Like MS, for instance. Or the initial attempts to get things rolling in the UK. Licensing. Institutional investors. We're all so anxious to see Leronlimab get its fair shake, to help the world, to make us money, that it's hard to not get frustrated with every delay or shift in strategy.

But you make the best decisions you can as the information in front of you allows. You plan and scheme, hoping the spark you keep throwing out catches and a fire erupts. Every so often it looks like you're good but the wind changes direction so you shift and get back after it. And sure, they are all trying to figure this thing out as it goes along to some extent, learning as they go, and you could argue someone with a ton of experience could have accelerated the timeline a little. But I trust all of them and have no doubt that it's going to happen. Even if they have to shift the goalposts a few more times before it does.
2

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 41

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 97

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 100

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 94

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 137

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 111

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 111

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 104

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Mission Rock Takes Charge of Seasons at Horsetooth

Updated Category News Views 20

Mission Rock Shakes Up Colorado's Apartment Market Here's one for the books: Mission Rock Residential, known for its no-nonsense approach to property management, just snagged a juicy piece of the market by taking over management at Seasons at Horsetooth Crossing in Fort Collins. Fort Collins isn't just some random name on the map—it's a hotbed for real estate, thanks to...

Continue Reading
Teck Resources Confirms Quarterly Dividend for Shareholders

Updated Category News Views 175

Teck Resources Declares New Dividend for Shareholders Teck Resources Limited (NYSE: TECK) has made an exciting announcement that will please its investors. The company has declared a quarterly dividend of $0.125 per share designated for its outstanding Class A common shares and Class B subordinate voting shares. This dividend is set to be paid on March 31 to all...

Continue Reading
Empowering Voices: The Impact of the AWDPI Conference

Updated Category News Views 300

Empowering Women Through Innovative Discussions The recent conference organized by the Asian Women Development Plan International brought together over 10,000 individuals passionate about empowering Asian women. This pivotal gathering, titled "The Conference of Asian Women Development International 2024", served as a beacon for women's issues, fostering a collaborative...

Continue Reading
O2Gold Shares Significant Updates on Quebec Aur Acquisition

Updated Category News Views 205

O2Gold's Exciting Update on Quebec Aur Acquisition O2Gold Inc. (NEX:OTGO.H), a dynamic player in the mineral exploration landscape, is thrilled to provide an update on its ongoing journey towards acquiring a gold mining exploration property in Quebec. This acquisition is through the purchase of Quebec Aur Ltd., with the transaction details specified in a share exchange...

Continue Reading
Skycorp Solar Group Limited Announces Major IPO Initiative

Updated Category News Views 187

Skycorp Solar Group Limited Announces Major IPO Initiative Skycorp Solar Group Limited (PN) has made a notable move by filing for an initial public offering (IPO) that encompasses 2,000,000 shares. The pricing is positioned attractively between $4 and $5 per share, appealing to a diverse range of potential investors. Understanding the IPO Process An IPO is a crucial step...

Continue Reading